PRISM Mid-Day Movers: Ethereum Bets and Alzheimers Trial Setback Stir Market Action

2025-06-30 14:00:32 ET

BitMine Rockets Nearly 400% on Ethereum Treasury Pivot and $250M Raise

BitMine Immersion Technologies ( BMNR ) skyrocketed 399.83% to top the PRISM Emerging Crypto Mining Index after announcing a $250 million private placement to fund an aggressive Ethereum treasury strategy . Backed by premier investors including Founders Fund, Pantera, Kraken, and Galaxy Digital, the move positions BitMine as one of the largest publicly traded ETH holders. Newly appointed Chairman Thomas Lee, co-founder of Fundstrat, described the initiative as a "convergence of traditional finance and crypto." The funds will be used to acquire ETH for long-term holdings, enabling BitMine to participate in staking and decentralized finance activities at the protocol level.

INmune Bio Crashes 60% After Alzheimer's Trial Misses Main Endpoint

INmune Bio Inc. ( INMB ) plunged 59.86%, leading declines in the PRISM Emerging Global Health Index , after reporting mixed results from its Phase 2 MINDFuL trial of XPro(TM) in early Alzheimer's disease . While the overall study failed to meet its primary cognitive endpoint, a predefined subgroup of patients with inflammatory biomarkers showed significant improvement in cognition, behavior, and disease-related biomarkers. Despite this signal of efficacy, the broader miss weighed heavily on investor sentiment. The company plans to seek Breakthrough Therapy Designation and engage with global regulators to define a Phase 3 path.

Other PRISM Mid-Day Movers:

• BigBear.ai Holdings, Inc. ( BBAI ) up 22.52%
• Plug Power Inc. ( PLUG ) up 20.03%
• Big 5 Sporting Goods Corporation ( BGFV ) up 18.91%
• Sera Prognostics, Inc. ( SERA ) down 25.43%

 

The post PRISM Mid-Day Movers: Ethereum Bets and Alzheimers Trial Setback Stir Market Action appeared first on PRISM MarketView .

COMTEX_466808938/2927/2025-06-30T13:00:32